Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Sheng Sun

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Bioconjugate Chemistry|July 21, 2005
Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding propertiesMaria Duca, Kahina Oussedik, Alexandre Ceccaldi, et al.
Chemistry & Biodiversity|December 29, 2006
Sequence-specific conjugates of oligo(2'-O-methylribonucleotides) and hairpin oligocarboxamide minor-groove binders: design, synthesis, and binding studies with double-stranded DNADarya S Novopashina, Alexandre N Sinyakov, Vladimir A Ryabinin, et al.
Journal of Cellular Biochemistry|August 10, 2005
Interactions between the rabbit CSN1 gene and the nuclear matrix of stably transfected HC11 mammary epithelial cells vary with its level of expressionKarine Poussin, Hélène Hayes, Alain Pauloin, et al.
The Journal of Biological Chemistry|November 29, 2001
Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase IPaola B Arimondo, Alexandre Boutorine, Brigitte Baldeyrou, et al.
Neoplasia (New York, N.Y.)|November 8, 2014
A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanomaJulian Biau, Flavien Devun, Wael Jdey, et al.
Nucleic Acids Research|July 11, 2003
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugatesPaola B Arimondo, Stéphane Angenault, Ludovic Halby, et al.
Frontiers in Oncology|November 30, 2019
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant TumorsNirmitha I Herath, Nathalie Berthault, Sylvain Thierry, et al.
Bioconjugate Chemistry|January 16, 2003
Synthesis and binding properties of oligo-2'-deoxyribonucleotides conjugated with triple-helix-specific intercalators: benzo[e] and benzo[g] pyridoindolesSerguei Vinogradov, Victoria Roig, Zinaida Sergueeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2016
Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Sylvain Thierry, Christophe Russo, et al.
Biochemistry|March 16, 2005
Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotidesPaola B Arimondo, Gary S Laco, Craig J Thomas, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Bioconjugate Chemistry|July 21, 2005
Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding propertiesMaria Duca, Kahina Oussedik, Alexandre Ceccaldi, et al.
Chemistry & Biodiversity|December 29, 2006
Sequence-specific conjugates of oligo(2'-O-methylribonucleotides) and hairpin oligocarboxamide minor-groove binders: design, synthesis, and binding studies with double-stranded DNADarya S Novopashina, Alexandre N Sinyakov, Vladimir A Ryabinin, et al.
Journal of Cellular Biochemistry|August 10, 2005
Interactions between the rabbit CSN1 gene and the nuclear matrix of stably transfected HC11 mammary epithelial cells vary with its level of expressionKarine Poussin, Hélène Hayes, Alain Pauloin, et al.
The Journal of Biological Chemistry|November 29, 2001
Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase IPaola B Arimondo, Alexandre Boutorine, Brigitte Baldeyrou, et al.
Neoplasia (New York, N.Y.)|November 8, 2014
A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanomaJulian Biau, Flavien Devun, Wael Jdey, et al.
Nucleic Acids Research|July 11, 2003
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugatesPaola B Arimondo, Stéphane Angenault, Ludovic Halby, et al.
Frontiers in Oncology|November 30, 2019
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant TumorsNirmitha I Herath, Nathalie Berthault, Sylvain Thierry, et al.
Bioconjugate Chemistry|January 16, 2003
Synthesis and binding properties of oligo-2'-deoxyribonucleotides conjugated with triple-helix-specific intercalators: benzo[e] and benzo[g] pyridoindolesSerguei Vinogradov, Victoria Roig, Zinaida Sergueeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2016
Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Sylvain Thierry, Christophe Russo, et al.
Biochemistry|March 16, 2005
Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotidesPaola B Arimondo, Gary S Laco, Craig J Thomas, et al.
Pageof 5